ImmunoPrecise Antibodies Ltd. filed its 40-F on Jul 10, 2023 for the period ending Apr 30, 2023. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +10.55% | +4.76% | -22.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.81% | 34.74M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- IPA Stock
- News ImmunoPrecise Antibodies Ltd.
- ImmunoPrecise Antibodies Ltd. Auditor Raises 'Going Concern' Doubt